| 0XN | Name: | 1,1-bis(4-fluorophenyl)methanamine | Formula: | C13 H11 F2 N | SMILES: | Fc1ccc(cc1)C(N)c2ccc(F)cc2 | InChi: | InChI=1S/C13H11F2N/c14-11-5-1-9(2-6-11)13(16)10-3-7-12(15)8-4-10/h1-8,13H,16H2 | Definition date: | 2012-08-29 | Last modified: | 2023-11-03 | Release date: | 2013-07-31 | Identifier: | 1,1-bis(4-fluorophenyl)methanamine |
|
| 0XO | Name: | 2-methyl-D-lysine | Formula: | C7 H16 N2 O2 | SMILES: | O=C(O)C(N)(CCCCN)C | InChi: | InChI=1S/C7H16N2O2/c1-7(9,6(10)11)4-2-3-5-8/h2-5,8-9H2,1H3,(H,10,11)/t7-/m1/s1 | Definition date: | 2012-08-29 | Last modified: | 2023-11-03 | Release date: | 2014-02-19 | Identifier: | 2-methyl-D-lysine |
|
| 0XQ | Name: | (2R)-2,8-diamino-2-methyloctanoic acid | Formula: | C9 H20 N2 O2 | SMILES: | O=C(O)C(N)(CCCCCCN)C | InChi: | InChI=1S/C9H20N2O2/c1-9(11,8(12)13)6-4-2-3-5-7-10/h2-7,10-11H2,1H3,(H,12,13)/t9-/m1/s1 | Definition date: | 2012-08-29 | Last modified: | 2023-11-03 | Release date: | 2014-02-19 | Identifier: | (2R)-2,8-diamino-2-methyloctanoic acid |
|
| NJU | Name: | 2-(3-chlorophenyl)-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)acetamide | Formula: | C17 H17 Cl N2 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cncc2CCCCc21 | InChi: | InChI=1S/C17H17ClN2O/c18-14-6-3-4-12(8-14)9-17(21)20-16-11-19-10-13-5-1-2-7-15(13)16/h3-4,6,8,10-11H,1-2,5,7,9H2,(H,20,21) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)acetamide |
|
| 0Y8 | Name: | (4R)-4-[(7-bromoisoquinolin-1-yl)oxy]-L-proline | Formula: | C14 H13 Br N2 O3 | SMILES: | O=C(O)C3NCC(Oc1nccc2c1cc(Br)cc2)C3 | InChi: | InChI=1S/C14H13BrN2O3/c15-9-2-1-8-3-4-16-13(11(8)5-9)20-10-6-12(14(18)19)17-7-10/h1-5,10,12,17H,6-7H2,(H,18,19)/t10-,12+/m1/s1 | Definition date: | 2012-09-12 | Last modified: | 2023-11-03 | Release date: | 2012-12-07 | Identifier: | (4R)-4-[(7-bromoisoquinolin-1-yl)oxy]-L-proline |
|
| 0Y9 | Name: | (1R,2S)-1-amino-2-ethenylcyclopropanecarboxylic acid | Formula: | C6 H9 N O2 | SMILES: | O=C(O)C1(N)CC1C=C | InChi: | InChI=1S/C6H9NO2/c1-2-4-3-6(4,7)5(8)9/h2,4H,1,3,7H2,(H,8,9)/t4-,6-/m1/s1 | Definition date: | 2012-09-12 | Last modified: | 2023-11-03 | Identifier: | (1R,2S)-1-amino-2-ethenylcyclopropanecarboxylic acid |
|
| 0YA | Name: | cyclopropanesulfonamide | Formula: | C3 H7 N O2 S | SMILES: | O=S(=O)(N)C1CC1 | InChi: | InChI=1S/C3H7NO2S/c4-7(5,6)3-1-2-3/h3H,1-2H2,(H2,4,5,6) | Definition date: | 2012-09-12 | Last modified: | 2023-11-03 | Release date: | 2012-12-07 | Identifier: | cyclopropanesulfonamide |
|
| 0YG | Name: | N-[(2Z)-2-amino-3-(4-hydroxyphenyl)prop-2-enoyl]glycine | Formula: | C11 H12 N2 O4 | SMILES: | NC(=Cc1ccc(O)cc1)C(=O)NCC(O)=O | InChi: | InChI=1S/C11H12N2O4/c12-9(11(17)13-6-10(15)16)5-7-1-3-8(14)4-2-7/h1-5,14H,6,12H2,(H,13,17)(H,15,16)/b9-5- | Definition date: | 2010-02-16 | Last modified: | 2023-11-03 | Identifier: | 2-[[(Z)-2-azanyl-3-(4-hydroxyphenyl)prop-2-enoyl]amino]ethanoic acid |
|
| NKU | Name: | 2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-methylacetamide | Formula: | C16 H15 Cl N4 O | SMILES: | Clc1cccc(c1)CN(C)C(=O)Cn1nnc2ccccc21 | InChi: | InChI=1S/C16H15ClN4O/c1-20(10-12-5-4-6-13(17)9-12)16(22)11-21-15-8-3-2-7-14(15)18-19-21/h2-9H,10-11H2,1H3 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-methylacetamide |
|
| NLB | Name: | 6-(benzyloxy)-L-norleucine | Formula: | C13 H19 N O3 | SMILES: | O=C(O)C(N)CCCCOCc1ccccc1 | InChi: | InChI=1S/C13H19NO3/c14-12(13(15)16)8-4-5-9-17-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10,14H2,(H,15,16)/t12-/m0/s1 | Definition date: | 2014-11-09 | Last modified: | 2023-11-03 | Release date: | 2015-02-11 | Identifier: | 6-(benzyloxy)-L-norleucine |
|
| NLE | Name: | NORLEUCINE | Formula: | C6 H13 N O2 | SMILES: | O=C(O)C(N)CCCC | InChi: | InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | L-norleucine |
|
| NLF | Name: | N-formyl-L-tryptophan | Formula: | C12 H12 N2 O3 | SMILES: | O=C(O)C(NC=O)Cc1c[NH]c2ccccc21 | InChi: | InChI=1S/C12H12N2O3/c15-7-14-11(12(16)17)5-8-6-13-10-4-2-1-3-9(8)10/h1-4,6-7,11,13H,5H2,(H,14,15)(H,16,17)/t11-/m0/s1 | Definition date: | 2022-04-05 | Last modified: | 2023-11-03 | Release date: | 2022-08-17 | Identifier: | N-formyl-L-tryptophan |
|
| NLO | Name: | O-METHYL-L-NORLEUCINE | Formula: | C7 H15 N O2 | SMILES: | O=C(OC)C(N)CCCC | InChi: | InChI=1S/C7H15NO2/c1-3-4-5-6(8)7(9)10-2/h6H,3-5,8H2,1-2H3/t6-/m0/s1 | Definition date: | 2004-01-27 | Last modified: | 2023-11-03 | Identifier: | methyl L-norleucinate |
|
| NLY | Name: | N-(4-aminobutyl)glycine | Formula: | C6 H14 N2 O2 | SMILES: | O=C(O)CNCCCCN | InChi: | InChI=1S/C6H14N2O2/c7-3-1-2-4-8-5-6(9)10/h8H,1-5,7H2,(H,9,10) | Definition date: | 2012-10-18 | Last modified: | 2023-11-03 | Release date: | 2013-10-09 | Identifier: | N-(4-aminobutyl)glycine |
|
| NM0 | Name: | 2-(3-chlorophenyl)-N-[(4R)-imidazo[1,2-a]pyridin-3-yl]acetamide | Formula: | C15 H12 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cnc2ccccn12 | InChi: | InChI=1S/C15H12ClN3O/c16-12-5-3-4-11(8-12)9-15(20)18-14-10-17-13-6-1-2-7-19(13)14/h1-8,10H,9H2,(H,18,20) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-[(4R)-imidazo[1,2-a]pyridin-3-yl]acetamide |
|
| NMC | Name: | N-CYCLOPROPYLMETHYL GLYCINE | Formula: | C6 H11 N O2 | SMILES: | O=C(O)CNCC1CC1 | InChi: | InChI=1S/C6H11NO2/c8-6(9)4-7-3-5-1-2-5/h5,7H,1-4H2,(H,8,9) | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | N-(cyclopropylmethyl)glycine |
|
| NMI | Name: | 3-(1-methyl-1H-indol-3-yl)propanoic acid | Formula: | C12 H13 N O2 | SMILES: | O=C(O)CCc2c1ccccc1n(c2)C | InChi: | InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15) | Definition date: | 2014-04-07 | Last modified: | 2023-11-03 | Release date: | 2014-06-18 | Identifier: | 3-(1-methyl-1H-indol-3-yl)propanoic acid |
|
| NMK | Name: | N-methyl Lysine | Formula: | C7 H17 N2 O2 | SMILES: | CN[CH](CCCC[NH3+])C(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-9-6(7(10)11)4-2-3-5-8/h6,9H,2-5,8H2,1H3,(H,10,11)/p+1/t6-/m0/s1 | Definition date: | 2018-10-10 | Last modified: | 2023-11-03 | Release date: | 2019-01-16 | Identifier: | [(5~{S})-5-(methylamino)-6-oxidanyl-6-oxidanylidene-hexyl]azanium |
|
| NMM | Name: | (2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid | Formula: | C7 H16 N4 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])NC | InChi: | InChI=1S/C7H16N4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11)/t5-/m0/s1 | Synonyms: | L-NMMA | Definition date: | 2005-12-28 | Last modified: | 2023-11-03 | Identifier: | N~5~-(N-methylcarbamimidoyl)-L-ornithine |
|
| 11Q | Name: | 1-(cyclohexylmethyl)-L-proline | Formula: | C12 H21 N O2 | SMILES: | O=C(O)C2N(CC1CCCCC1)CCC2 | InChi: | InChI=1S/C12H21NO2/c14-12(15)11-7-4-8-13(11)9-10-5-2-1-3-6-10/h10-11H,1-9H2,(H,14,15)/t11-/m0/s1 | Definition date: | 2012-09-29 | Last modified: | 2023-11-03 | Release date: | 2013-04-03 | Identifier: | 1-(cyclohexylmethyl)-L-proline |
|
| NO0 | Name: | 2-(3-ethynylphenyl)-N-(isoquinolin-4-yl)acetamide | Formula: | C19 H14 N2 O | SMILES: | C#Cc1cccc(c1)CC(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C19H14N2O/c1-2-14-6-5-7-15(10-14)11-19(22)21-18-13-20-12-16-8-3-4-9-17(16)18/h1,3-10,12-13H,11H2,(H,21,22) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-ethynylphenyl)-N-(isoquinolin-4-yl)acetamide |
|
| NOI | Name: | 2-(3-chlorophenyl)-N-(1-methyl-1H-imidazol-5-yl)acetamide | Formula: | C12 H12 Cl N3 O | SMILES: | O=C(Nc1cncn1C)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C12H12ClN3O/c1-16-8-14-7-11(16)15-12(17)6-9-3-2-4-10(13)5-9/h2-5,7-8H,6H2,1H3,(H,15,17) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1-methyl-1H-imidazol-5-yl)acetamide |
|
| NOR | Name: | CYCLOHEXYL-NORSTATINE | Formula: | C13 H25 N O3 | SMILES: | O=C(OC(C)C)C(O)C(N)CC1CCCCC1 | InChi: | InChI=1S/C13H25NO3/c1-9(2)17-13(16)12(15)11(14)8-10-6-4-3-5-7-10/h9-12,15H,3-8,14H2,1-2H3/t11-,12+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | propan-2-yl (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutanoate |
|
| 13E | Name: | N-[(2S)-2-amino-3-phenylpropyl]-L-methionine | Formula: | C14 H22 N2 O2 S | SMILES: | O=C(O)C(NCC(N)Cc1ccccc1)CCSC | InChi: | InChI=1S/C14H22N2O2S/c1-19-8-7-13(14(17)18)16-10-12(15)9-11-5-3-2-4-6-11/h2-6,12-13,16H,7-10,15H2,1H3,(H,17,18)/t12-,13-/m0/s1 | Definition date: | 2012-10-02 | Last modified: | 2023-11-03 | Release date: | 2012-12-07 | Identifier: | N-[(2S)-2-amino-3-phenylpropyl]-L-methionine |
|
| NQ3 | Name: | (1M,3P)-1-(3-chlorophenyl)-3-(4-methylpyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one | Formula: | C15 H12 Cl N3 O | SMILES: | Clc1cccc(c1)N1C=CN(c2cnccc2C)C1=O | InChi: | InChI=1S/C15H12ClN3O/c1-11-5-6-17-10-14(11)19-8-7-18(15(19)20)13-4-2-3-12(16)9-13/h2-10H,1H3 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (1M,3P)-1-(3-chlorophenyl)-3-(4-methylpyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one |
|